Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Shares Outstanding (Weighted Average) (2016 - 2020)

Historic Shares Outstanding (Weighted Average) for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $16.0 million.

  • Larimar Therapeutics' Shares Outstanding (Weighted Average) rose 16241.92% to $16.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $16.0 million, marking a year-over-year increase of 16241.92%. This contributed to the annual value of $6.1 million for FY2019, which is 8355.32% down from last year.
  • Latest data reveals that Larimar Therapeutics reported Shares Outstanding (Weighted Average) of $16.0 million as of Q3 2020, which was up 16241.92% from $9.4 million recorded in Q2 2020.
  • Larimar Therapeutics' 5-year Shares Outstanding (Weighted Average) high stood at $37.3 million for Q1 2019, and its period low was $6.1 million during Q2 2019.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $22.9 million, with a median of $27.3 million in 2016.
  • The largest annual percentage gain for Larimar Therapeutics' Shares Outstanding (Weighted Average) in the last 5 years was 16241.92% (2020), contrasted with its biggest fall of 8367.57% (2020).
  • Larimar Therapeutics' Shares Outstanding (Weighted Average) (Quarter) stood at $27.3 million in 2016, then rose by 0.5% to $27.4 million in 2017, then skyrocketed by 35.0% to $37.0 million in 2018, then crashed by 83.55% to $6.1 million in 2019, then surged by 162.42% to $16.0 million in 2020.
  • Its Shares Outstanding (Weighted Average) stands at $16.0 million for Q3 2020, versus $9.4 million for Q2 2020 and $6.1 million for Q1 2020.